1.Biological characteristics of liver zonation and its role in disease and aging
Peiyuan GU ; Jingxin XIN ; Keling YIN ; Changxu ZHOU ; Ran ZHANG ; Shanshan SHAO
Chinese Journal of Hepatology 2025;33(6):601-606
The liver is the largest visceral organ in the human body, responsible for multiple important functions such as metabolism, detoxification, nutrient storage, and immune regulation. Hepatocytes located along the portal-central vein axis have heterogeneity in gene expression and function, which led to the concept of liver zonation. Cells in different regions play different roles in metabolic processes, and the coordination and cooperation between these cells are crucial for maintaining normal liver function. In recent years, the advancements in single-cell genomics and spatial transcriptomics technologies have significantly improved our understanding of liver zonation. This article summarizes the important role of metabolic zonation in maintaining liver function and its relationship with disease and aging, providing a theoretical basis for further research and therapeutic strategies.
2.Biological characteristics of liver zonation and its role in disease and aging
Peiyuan GU ; Jingxin XIN ; Keling YIN ; Changxu ZHOU ; Ran ZHANG ; Shanshan SHAO
Chinese Journal of Hepatology 2025;33(6):601-606
The liver is the largest visceral organ in the human body, responsible for multiple important functions such as metabolism, detoxification, nutrient storage, and immune regulation. Hepatocytes located along the portal-central vein axis have heterogeneity in gene expression and function, which led to the concept of liver zonation. Cells in different regions play different roles in metabolic processes, and the coordination and cooperation between these cells are crucial for maintaining normal liver function. In recent years, the advancements in single-cell genomics and spatial transcriptomics technologies have significantly improved our understanding of liver zonation. This article summarizes the important role of metabolic zonation in maintaining liver function and its relationship with disease and aging, providing a theoretical basis for further research and therapeutic strategies.
3.Research progress in the role of m6A methylation in the pathogenesis of myocardial remodeling after myocardial infarction
Changxu XIE ; Shuaijie GUO ; Siqi CHEN ; Lei ZHANG ; Weihong LIU ; Sinai LI ; Mingxue ZHOU
Chinese Journal of Arteriosclerosis 2024;32(7):613-620
Myocardial infarction is the most common cause of heart failure,and myocardial remodeling can occur after infarction,thus contributing to the progression of heart failure.The occurrence of post-infarction ventricular remode-ling is closely related to m6A methylation.m6A methylation is a reversible and highly dynamic process.This process is mainly mediated by m6A methylation positive and negative regulatory enzymes and is involved in the occurrence of post-in-farction myocardial remodeling through mechanisms such as cellular autophagy.This article mainly reviews relevant litera-ture in recent years.Firstly,a brief introduction is given to m6A methylation,followed by an introduction to the role of m6A methylase in regulating myocardial remodeling.Finally,a summary analysis is conducted on the mechanism of m6A methylation in regulating myocardial remodeling from the perspectives of autophagy,inflammation,cell apoptosis,calcium ion homeostasis,extracellular matrix remodeling,and ferroptosis.The feasibility of using m6A methylation serological de-tection as a diagnostic tool for myocardial remodeling after myocardial infarction is discussed,in order to provide reference for related research.
4.Exploring the Mechanism of Acanthopanax Senticosus in the Treatment of Alzheimer’s Disease Based on GEO Data Mining and Network Pharmacology
WANG Yanyan ; TANG Weiwei ; GAO Qi ; CHEN Chen ; SHAO Mengting ; LI Changxu ; LIU Jiayue ; ZHOU Hairui ; ZHAO Hong
Chinese Journal of Modern Applied Pharmacy 2023;40(16):2192-2202
OBJECTIVE To screen the potential drug targets and signaling pathways of Acanthopanax senticosus for the treatment of Alzheimer’s disease(AD) by bioinformatics and network pharmacology-based approach, and to preliminarily validate its efficacy. METHODS The ingredients of Acanthopanax senticosus were obtained through literature, the ingredients were screened by Swiss ADME, and potential targets were predicted by Swiss Target Prediction. AD’s differentially expressed genes were screened from the GSE28146 dataset. The target of Acanthopanax senticosus and AD target were mapped to construct a “drug-ingredients-potential target-disease” network and protein-protein interaction network. The DAVID database was used for GO and KEGG enrichment analysis. Autodock software was used to verify the molecular docking between key active ingredients and core targets. AD mice model was induced by D-galactose combined with aluminum chloride. Morris water maze test was performed to examine the learning memory ability of each group of mice and to observe the pathological changes in the hippocampus of mice. RESULTS Screened to obtain 24 active components and 74 potential targets of Acanthopanax senticosus for the treatment of AD. “Drug-ingredients-potential target-disease” network indicated that quercetin and kaempferol were the main components of Acanthopanax senticosus for the treatment of AD, and the protein-protein interaction network indicated that STAT3, MAPK1 and PIK3CA were the key targets. Obtained 366 GO enrichment entries(P<0.01) and 109 KEGG enrichment pathways(P<0.01). It mainly involved PI3K-AKT, AGE-RAGE, TNF and other pathways. The molecular docking results showed that the main active ingredients of Acanthopanax senticosus were able to bind well to the main targets. The in vivo pharmacological results showed that Acanthopanax senticosus could significantly improve the learning and memory ability of mice, reduce hippocampal tissue damage, and decrease the content of TNF-α, IL-6, and IL-1β in hippocampal tissue. CONCLUSION Acanthopanax senticosus may exert anti-AD effects by inhibiting the expression of inflammatory factors and reducing inflammatory damage.
5.Role of H1 receptor in inflammatory response during ventilator-induced lung injury in rats
Wenyu ZHOU ; Chao QIN ; Changxu ZHENG ; Yonghao YU
Chinese Journal of Anesthesiology 2019;39(6):758-760
Objective To evaluate the role of H1 receptor in inflammatory responses during ventila-tor-induced lung injury ( VILI) in rats. Methods Thirty clean-grade healthy male Sprague-Dawley rats, aged 9-10 weeks, weighing 250-300 g, were divided into 3 groups ( n=10 each) using a random number table method: control group (group C), VILI group (group V) and H1 receptor antagonist clemastine group ( group Cle) . The animals were anesthetized and tracheostomized, and the rats in group C kept spon-taneous breathing. The rats were mechanically ventilated for 4 h with the tidal volume of 40 ml/kg, respira-tory rate 40 breaths/min, inspiratory/expiratory ratio 1 : 1, and inspired oxygen fraction ratio 21% in group V. In group Cle, clemastine 0. 9 mg/kg was intramuscularly injected at 30 min before anesthesia, the ani-mals were tracheostomized after being anesthetized, and then the rats were mechanically ventilated with the same ventilator settings as group V. The animals were sacrificed at 4 h of ventilation, bronchoalveolar lav-age fluid ( BALF) was collected for determination of concentrations of total protein, interleukin-6 ( IL-6) , tumor necrosis factor-alpha ( TNF-α) , and the lung specimens were obtained for microscopic examination of pathologic changes and for determination of wet/dry weight ratio ( W/D ratio ) . Results Compared with group C, the concentrations of total protein, IL-6 and TNF-αin BALF and W/D ratio were significantly in-creased in group V (P<0. 05). Compared with group V, the concentrations of total protein, IL-6 and TNF-αin BALF and W/D ratio were significantly decreased in group Cle ( P<0. 05) . The pathologic chan-ges of lung tissues were significantly attenuated in group Cle as compared with group V. Conclusion H1 receptor is involved in the process of inflammatory responses during VILI in rats.
6.Medium optimization for antagonistic Streptomyces S24 and its inhibition on Aspergillus flavus.
Qisheng ZHOU ; Xunli LIU ; Nan ZHANG ; Zhen SONG ; Nianquan QIU ; Benfeng ZHANG ; Hui GUO ; Changxu LÜ ; Jian YU
Chinese Journal of Biotechnology 2011;27(2):203-211
Streptomyces S24 has broad spectrum against Aspergillus spp. in food and feed, such as Aspergillus flavus, Aspergillus niger and Asperegillus alutacells. The objective of this study was to improve the production of antifungal substances produced by S24 and to test their inhibitory effects on Aspergillus flavus. By using one-factor-at-a-time experiment and orthogonal design method, we optimized the fermentation medium. The composition of an optimized medium for the production of antifungal substances contained (g/L): starch soluble, 10; Glucose, 40; yeast extract, 8; soybean powder, 24; KH2PO4 4; and CaCO3 0.8. As a result, the productivity of antifungal substances could reach to 10 235.45 microg/mL, and this value was 2.81 times higher than that of initial medium before optimization. Additionally, inhibitory effects of the products on Aspergillus flavus were analyzed. Antagonistic tests indicated that the antifungal substances greatly inhibited mycelium growth and spores germination of Aspergillus flavus. We observed through microscope that the mycelia grew abnormally, such as contorting, bulging, vacuole increasing and the cytoplasmic contents inside effusing and the spores appeared unusual, such as gathering, deforming, cytoplasmic contents inside effusing and fracturing.
Adsorption
;
Antifungal Agents
;
chemistry
;
isolation & purification
;
pharmacology
;
Aspergillus flavus
;
drug effects
;
growth & development
;
Aspergillus niger
;
drug effects
;
growth & development
;
Culture Media
;
chemistry
;
Food Contamination
;
prevention & control
;
Streptomyces
;
chemistry
;
growth & development
;
metabolism


Result Analysis
Print
Save
E-mail